Want to monitor VRDN?
Get notified when price crosses targets, volume spikes, or RSI hits oversold
Create free account to monitor VRDNmiragen therapeutics, inc. , (nasdaq: mgen), is a biopharmaceutical company discovering and developing innovative microrna (mirna)-targeting therapies to improve human health, specifically in disease areas of high unmet medical need. the company leverages in-house expertise in mirna biology, oligonucleotide chemistry, and drug development to evaluate and advance best-in-class technologies and high-potential drug candidates for its own pipeline or in conjunction with strategic partners.